Login
Login
Subscribe

Real Clinics. Real Patients. Real Oncology.

Home/ News
Recent Updates

Researchers Find a Minimally Invasive Option for Recurrent NMIBC

In DaBlaCa-13, intravesical mitomycin C reduced procedural burden and matched TURBT outcomes in select recurrent NMIBC patients.

August 10, 2026
FDA Approvals

Emory Research Helps Lead to New FDA-Approved Treatment For Aggressive Breast Cancer

Emory Research Helps Lead to New FDA-Approved Treatment For Aggressive Breast Cancer

August 10, 2026
Recent Updates

Atezolizumab Adds No Survival Benefit to BCG for High-Risk NMIBC

Atezolizumab Adds No Survival Benefit to BCG for High-Risk NMIBC

August 3, 2026

Image without description (no attachment ID found)
Recent Updates

South Texas-Based Oncology Consultants Joins American Oncology Network

South Texas-Based Oncology Consultants Joins American Oncology Network

August 3, 2026

Image without description (no attachment ID found)
Recent Updates

Epigenetic Therapy Shows Promise Against Treatment-Resistant AML

Epigenetic Therapy Shows Promise Against Treatment-Resistant AML

July 27, 2026
Recent Updates

Immunotherapy Shows Promise in Sparing Cystectomy for High-Risk BCG-Unresponsive NMIBC

Immunotherapy Shows Promise in Sparing Cystectomy for High-Risk BCG-Unresponsive NMIBC

July 27, 2026
Recent Updates

Active Surveillance Matches BCG Therapy for Select Patients With High-Grade T1 Bladder Cancer

Active Surveillance Matches BCG Therapy for Select Patients With High-Grade T1 Bladder Cancer

July 20, 2026

Image without description (no attachment ID found)
Recent Updates

Practices Partner to Increase Access to Cancer Care in Northeastern Indiana Communities

Practices Partner to Increase Access to Cancer Care in Northeastern Indiana Communities

July 20, 2026
Clinical Trials

New Trial Data Reshaping Patient Selection for Bladder Cancer Maintenance Immunotherapy

New Trial Data Reshaping Patient Selection for Bladder Cancer Maintenance Immunotherapy

July 14, 2026

Image without description (no attachment ID found)
Recent Updates

Messino Cancer Centers Opens Second Asheville, NC, Clinic

Messino Cancer Centers Opens Second Asheville, NC, Clinic

July 14, 2026

Image without description (no attachment ID found)
Clinical Trials

MM BCG Plus Mitomycin: A Practical Alternative Amid Global BCG Shortage

MM BCG Plus Mitomycin: A Practical Alternative Amid Global BCG Shortage

July 14, 2026
Clinical Trials

Fourth-Line Pimitespib Preserves QoL in Patients With Advanced GIST

Fourth-Line Pimitespib Preserves QoL in Patients With Advanced GIST

June 26, 2026
Clinical Trials

Enfortumab Vedotin Plus Pembrolizumab Combo Shows Promise for Cisplatin-Ineligible Bladder Cancer

Enfortumab Vedotin Plus Pembrolizumab Combo Shows Promise for Cisplatin-Ineligible Bladder Cancer

June 26, 2026
Clinical Trials

Pembrolizumab-Chemo Combo Enhances Advanced Endometrial Cancer Care

Pembrolizumab-Chemo Combo Enhances Advanced Endometrial Cancer Care

June 26, 2026

Image without description (no attachment ID found)
Recent Updates

Hawai’i Cancer Care Opens Third Clinic

Hawai’i Cancer Care Opens Third Clinic

June 26, 2026

Image without description (no attachment ID found)
Recent Updates

Daraxonrasib Improves Survival Outcomes in Previously Treated Metastatic PDAC

Daraxonrasib Improves Survival Outcomes in Previously Treated Metastatic PDAC

June 1, 2026

Image without description (no attachment ID found)
Recent Updates

Improving Disease Control in Dedifferentiated Liposarcoma

Improving Disease Control in Dedifferentiated Liposarcoma

June 1, 2026

Image without description (no attachment ID found)
Recent Updates

Adjuvant Selpercatinib Improves Outcomes in RET-Positive Early-Stage NSCLC

Adjuvant Selpercatinib Improves Outcomes in RET-Positive Early-Stage NSCLC

June 1, 2026

Image without description (no attachment ID found)
Recent Updates

Ivonescimab Plus Chemotherapy Extends OS in Advanced Squamous NSCLC

Ivonescimab Plus Chemotherapy Extends OS in Advanced Squamous NSCLC

June 1, 2026

Image without description (no attachment ID found)
Recent Updates

PROTEUS Supports Perioperative Apalutamide Plus ADT for High-Risk Prostate Cancer

PROTEUS Supports Perioperative Apalutamide Plus ADT for High-Risk Prostate Cancer

June 1, 2026

Image without description (no attachment ID found)
Clinical Trials

Pembrolizumab-Chemo Combo Enhances Advanced Endometrial Cancer Care

Pembrolizumab-Chemo Combo Enhances Advanced Endometrial Cancer Care

May 29, 2026

Image without description (no attachment ID found)
Recent Updates

Introducing In Practice: Your New Go-To for All Things Community Oncology

Introducing In Practice: Your New Go-To for All Things Community Oncology

Hina Mehreen

May 29, 2026

Image without description (no attachment ID found)
FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

April 16, 2026

Image without description (no attachment ID found)
FDA Approvals

Reconsidering Venetoclax Dosing With Azole Antifungals

Reconsidering Venetoclax Dosing With Azole Antifungals

Grant Drew, PharmD; Kiwon Park, PharmD, et al.

April 16, 2026

Image without description (no attachment ID found)
Clinical Trials

North American Enrollment in Clinical Trials

North American Enrollment in Clinical Trials

Ming-Hei Tai, PharmD, BCOP

April 15, 2026

Recent Updates

The latest breakthroughs, research highlights, and industry developments in oncology.

View More
Recent Updates

Researchers Find a Minimally Invasive Option for Recurrent NMIBC

Researchers Find a Minimally Invasive Option for Recurrent NMIBC

August 10, 2026
Recent Updates

Atezolizumab Adds No Survival Benefit to BCG for High-Risk NMIBC

Atezolizumab Adds No Survival Benefit to BCG for High-Risk NMIBC

August 3, 2026

Image without description (no attachment ID found)
Recent Updates

South Texas-Based Oncology Consultants Joins American Oncology Network

South Texas-Based Oncology Consultants Joins American Oncology Network

August 3, 2026
Recent Updates

Researchers Find a Minimally Invasive Option for Recurrent NMIBC

Researchers Find a Minimally Invasive Option for Recurrent NMIBC

August 10, 2026
Recent Updates

Atezolizumab Adds No Survival Benefit to BCG for High-Risk NMIBC

Atezolizumab Adds No Survival Benefit to BCG for High-Risk NMIBC

August 3, 2026

FDA Approvals

Updates on recent FDA approvals, label expansions, and regulatory decisions that may affect everyday oncology practice.

View More
FDA Approvals

Emory Research Helps Lead to New FDA-Approved Treatment For Aggressive Breast Cancer

Emory Research Helps Lead to New FDA-Approved Treatment For Aggressive Breast Cancer

August 10, 2026

Image without description (no attachment ID found)
FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

April 16, 2026

Image without description (no attachment ID found)
FDA Approvals

Reconsidering Venetoclax Dosing With Azole Antifungals

Reconsidering Venetoclax Dosing With Azole Antifungals

Grant Drew, PharmD; Kiwon Park, PharmD, et al.

April 16, 2026
FDA Approvals

Emory Research Helps Lead to New FDA-Approved Treatment For Aggressive Breast Cancer

Emory Research Helps Lead to New FDA-Approved Treatment For Aggressive Breast Cancer

August 10, 2026

Image without description (no attachment ID found)
FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

April 16, 2026

Clinical Trials

Stay current on pivotal oncology trials with practice-changing results, recruiting studies, and key readouts relevant to community cancer care.

View More
Clinical Trials

New Trial Data Reshaping Patient Selection for Bladder Cancer Maintenance Immunotherapy

New Trial Data Reshaping Patient Selection for Bladder Cancer Maintenance Immunotherapy

July 14, 2026

Image without description (no attachment ID found)
Clinical Trials

MM BCG Plus Mitomycin: A Practical Alternative Amid Global BCG Shortage

MM BCG Plus Mitomycin: A Practical Alternative Amid Global BCG Shortage

July 14, 2026
Clinical Trials

Fourth-Line Pimitespib Preserves QoL in Patients With Advanced GIST

Fourth-Line Pimitespib Preserves QoL in Patients With Advanced GIST

June 26, 2026
Clinical Trials

New Trial Data Reshaping Patient Selection for Bladder Cancer Maintenance Immunotherapy

New Trial Data Reshaping Patient Selection for Bladder Cancer Maintenance Immunotherapy

July 14, 2026

Image without description (no attachment ID found)
Clinical Trials

MM BCG Plus Mitomycin: A Practical Alternative Amid Global BCG Shortage

MM BCG Plus Mitomycin: A Practical Alternative Amid Global BCG Shortage

July 14, 2026

What are you
looking for?

POPULAR SEARCHES

Bladder Cancer

Blood-Based Tests

Breast Cancer

Cancer Types